Di-aryl ethers and their derivatives as anti-cancer agents
US6169104A · kind A · utility
22Cited by
7References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 25, 1998 |
| Grant date | Jan 2, 2001 |
| Priority date | — |
| Expiry date | Mar 25, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, inter alia, to compounds that bind tubulin and exhibit anti-mitotic properties and to methods of using such compounds to inhibit abnormal cell mitosis and, in particular, to inhibit tumor cell growth. In addition, methods are presented of treating mammalian diseases associated with undesired and uncontrolled angiogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.